Evidence map›Paper›PMID 37792582›Full record

ArticleCancer science2023

Single-cell transcriptomic analysis of gingivo-buccal oral cancer reveals two dominant cellular programs.

Sillarine Kurkalang, Sumitava Roy, Arunima Acharya, Paramita Mazumder, Somnath Mazumder, Subrata Patra, Shekhar Ghosh, Sumanta Sarkar, Sudip Kundu, Nidhan Kumar Biswas and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. INHBABMC cancer · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sillarine KurkalangNational Institute of Biomedical Genomics, Kalyani, India.
Sumitava RoyNational Institute of Biomedical Genomics, Kalyani, India.
Arunima AcharyaNational Institute of Biomedical Genomics, Kalyani, India.
Paramita MazumderDepartment of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India.
Somnath MazumderNational Institute of Biomedical Genomics, Kalyani, India.
Subrata PatraNational Institute of Biomedical Genomics, Kalyani, India.
Shekhar GhoshNational Institute of Biomedical Genomics, Kalyani, India.
Sumanta SarkarNational Institute of Biomedical Genomics, Kalyani, India.
Sudip KunduNational Institute of Biomedical Genomics, Kalyani, India.
Nidhan Kumar BiswasNational Institute of Biomedical Genomics, Kalyani, India.
Sandip GhoseDepartment of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India.
Partha P MajumderNational Institute of Biomedical Genomics, Kalyani, India.
Arindam MaitraNational Institute of Biomedical Genomics, Kalyani, India.ORCID https://orcid.org/0000-0002-0249-8856
National Institute of Biomedical Genomics · INDr. R. Ahmed Dental College and Hospital · INRegional Centre for Biotechnology · IN

Funding

Wellcome Trust
6 · The paper itself

Abstract

Oral squamous cell carcinoma of the gingivo-buccal region (OSCC-GB) is the most common cancer among men in India, and is associated with poor prognosis and frequent recurrence. Cellular heterogeneity in OSCC-GB was investigated by single-cell RNA sequencing of tumors derived from the oral cavity of 12 OSCC-GB patients, 3 of whom had concomitant presence of a precancerous lesion (oral submucous fibrosis [OSMF]). Unique malignant cell types, features, and phenotypic shifts in the stromal cell population were identified in oral tumors with associated submucous fibrosis. Expression levels of FOS, ATP1A, and DUSP1 provided robust discrimination between tumors with or without the concomitant presence of OSMF. Malignant cell populations shared between tumors with and without OSMF were enriched with the expression of partial epithelial-mesenchymal transition (pEMT) or fetal cell type signatures indicative of two dominant cellular programs in OSCC-GB-pEMT and fetal cellular reprogramming. Malignant cells exhibiting fetal cellular and pEMT programs were enriched with the expression of immune-related pathway genes known to be involved in antitumor immune response. In the tumor microenvironment, higher infiltration of immune cells than the stromal cells was observed. The T cell population was large in tumors and diverse subtypes of T cells with varying levels of infiltration were found. We also detected double-negative PLCG2

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsOral Submucous FibrosisGene Expression ProfilingHumansMaleTumor Microenvironmentcellular diversityfetal cell-type signaturepartial epithelial-mesenchymal transitionsingle-cell RNA sequencingtumor ecosystem

Identifiers

PMID37792582
PMCPMC10728019
OpenAlexW4387332078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.